Phase I clinical safety and efficacy observation of αPD-1-mesoCAR-T cells in the treatment of advanced gynecologic cancer.Yong Xia, Qijun Qian, Zhongzheng Zhu et al.|Journal of Clinical Oncology|2022Cited by 0